HopeStage
Back to all studies
RecruitingNCT07079215

A medical device for opioid withdrawal symptoms

About this titleRead the official source — NCT07079215
Device studyAges 19–80South KoreaAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 19 years to 80 years.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 30, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
24
Sponsor
Nu Eyne Co., Ltd.
Sponsor type
Other organization
Study type
Device
Intervention type
Device
Locations
South Korea
Age range
From 19 Years to 80 Years
Official registry ID
NCT07079215
Official title
Show the full official title

A Single Center, Double-Blind, Randomized, Sham-Controlled, Parallel Design, Exploratory Clinical Trial to Evaluate the Safety and Efficacy of a Medical Device for the Treatment of Opioid Withdrawal Symptoms

Recruitment & locations

Currently recruiting

Daegu

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Nu Eyne Co., Ltd.

Who can participate?

Listed age limits: 19 years to 80 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies